Geneos Wealth Management Inc. Teva Pharmaceutical Industries LTD Transaction History
Geneos Wealth Management Inc.
- $2.77 Billion
- Q4 2024
A detailed history of Geneos Wealth Management Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 23,122 shares of TEVA stock, worth $394,461. This represents 0.02% of its overall portfolio holdings.
Number of Shares
23,122
Previous 42,522
45.62%
Holding current value
$394,461
Previous $766,000
33.55%
% of portfolio
0.02%
Previous 0.03%
Shares
36 transactions
Others Institutions Holding TEVA
# of Institutions
638Shares Held
580MCall Options Held
19.6MPut Options Held
6.77M-
Black Rock Inc. New York, NY43MShares$733 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.2MShares$618 Million35.87% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L334.5MShares$589 Million5.5% of portfolio
-
Menora Mivtachim Holdings Ltd.28.8MShares$492 Million3.32% of portfolio
-
Exor Capital LLP London, X027.2MShares$464 Million17.5% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $18.9B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...